4BIO Capital

What they do

Founded in 2014, 4BIO Capital is a highly specialized life sciences venture capital firm dedicated exclusively to the advanced therapies sector. The firm is uniquely positioned in the market due to its deeply technical team, which comprises leading advanced therapy scientists and physician-scientists. 4BIO is known for its hands-on company creation and incubation strategy, frequently spinning out companies directly from top-tier academic institutions and supporting them through clinical development and manufacturing bottlenecks. They have built a strong reputation globally, particularly bridging the UK, US, and Japanese biotech ecosystems.

What they look for

4BIO’s objective is to invest in, support, and grow early-stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring sustainable access to these potentially curative therapies for all patients. They prioritize novel technologies that resolve the largest industry pain points of advanced therapies in order to enable next-generation therapeutic assets.

Stage

Pre-seed, Seed, Series A, Series B+

Sectors

Healthcare, Deeptech

Based

London, GB